We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Angel Biotech | LSE:ABH | London | Ordinary Share | GB00B0HZJ337 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.05 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMABH
RNS Number : 1563C
Angel Biotechnology Holdings Plc
26 April 2012
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) --------------------------------------------------------------------------------------- 1. Identity of the issuer or the underlying ANGEL BIOTECHNOLOGY HOLDINGS PLC issuer of existing shares to which voting rights are attached: (ii) -------------------------------------------------- ----------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): --------------------------------------------------------------------------------------- An acquisition or disposal of voting rights u ------------------------------------------------------------------------------ ------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------------------ ------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------------------ ------- An event changing the breakdown of voting rights u ------------------------------------------------------------------------------ ------- Other (please specify): ------------------- --------------------------------------------------------- ------- 3. Full name of person(s) subject HARGREAVE HALE LIMITED to the notification obligation: (iii) -------------------------------------------- ----------------------------------------- 4. Full name of shareholder(s) DISCRETIONARY CLIENTS (if different from 3.):(iv) -------------------------------------------- ----------------------------------------- 5. Date of the transaction and date 16 APRIL 2012 on which the threshold is crossed or reached: (v) -------------------------------------------- ----------------------------------------- 6. Date on which issuer notified: 17 APRIL 2012 -------------------------------------------- ----------------------------------------- 7. Threshold(s) that is/are crossed or reached: (vi, vii) 5% -------------------------------------------- ----------------------------------------- 8. Notified details: --------------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) --------------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE ------------- ----------------------------------- ----------------------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights ------------- ---------------- ----------------- ------------------------- ----------------------- ------------------- Direct Indirect Direct Indirect Direct Indirect (xi) (xii) ------------- ----- ----- ------ ----- ------- ---------------- ------- -------------- ------- ---------- GB00B0HZJ337 41,500,000 41,500,000 226,500,000 226,500,000 6.0022% ---------------- ----------------- ------- ---------------- ------- -------------- ------- ---------- B: Qualifying Financial Instruments --------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction --------------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion Period rights that may rights (xiv) be acquired if the instrument is exercised/ converted. ------------------------ ----------------- ---------------------------- --------------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) --------------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction --------------------------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting rights financial price date (xvii) Conversion rights instrument (xix, xx) instrument period refers to (xviii) ----------------- ---------------- ------------- -------------- ---------------------------- ------------------------- Nominal Delta ----------------- ---------------- ------------- -------------- ---------------------------- ------------- ---------- Total (A+B+C) --------------------------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------------------------ ------------------------------------------------------- 226,500,000 6.0022% ------------------------------------------------------------------ ------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------------------- All of these shares are held for unit trusts operated by Marlborough Fund Managers Ltd for whom Hargreave Hale Ltd manages the investments on a discretionary basis. Proxy Voting: --------------------------------------------------------------------------------------- 10. Name of the proxy holder: ----------------------------------------------------- -------------------------------- 11. Number of voting rights proxy holder will cease to hold: ----------------------------------------------------- -------------------------------- 12. Date on which proxy holder will cease to hold voting rights: ----------------------------------------------------- -------------------------------- 185,000,000 shares were purchased 13. Additional information: from the placing of 500,000,000 shares which were admitted to AIM on 16/04/2012. ---------------------------------------- --------------------------------------------- 14. Contact name: David Clueit ---------------------------------------- --------------------------------------------- 15. Contact telephone number: 01253 754739 ---------------------------------------- ---------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLIFMTTMBITBJT
1 Year Angel Biotechnology Chart |
1 Month Angel Biotechnology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions